SCA Pharmaceuticals: Drug Recall
Recall #D-0830-2022 · 04/25/2022
Class II: Risk
Recall Details
- Recall Number
- D-0830-2022
- Classification
- Class II
- Product Type
- Drug
- Recalling Firm
- SCA Pharmaceuticals
- Status
- Terminated
- Date Initiated
- 04/25/2022
- Location
- Windsor, CT, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 424 bags
Reason for Recall
CGMP Deviations
Product Description
Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bags, Rx only, SCA Pharmaceuticals Windsor, CT 06095, NDC 70004-0231-32
Distribution Pattern
Product was distributed nationwide within the United States
Other Recalls by SCA Pharmaceuticals
- Class II: Risk 07/20/2023
- Class III: Low Risk 04/10/2023
- Class III: Low Risk 02/24/2023
- Class II: Risk 04/25/2022
- Class II: Risk 04/25/2022
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.